{
  "subset": "contraindication",
  "disease": "Limb girdle muscular dystrophy",
  "relation": "contraindication",
  "gold_drugs": [
    "arry-371797",
    "ascorbic acid",
    "atyr1940",
    "bay63-2521) + riociguat (adempas",
    "bbp-418",
    "coenzyme q10 + lisinopril",
    "corticosteroid",
    "cyclophosphamide",
    "deflazacort",
    "doxorubicin",
    "frovatriptan",
    "glucocorticoid",
    "lenalidomide",
    "myo-029",
    "pf 06252616",
    "pf-07265803",
    "prednisone",
    "raavrh74.mhck7.dysf.dv",
    "rituximab",
    "srp-9004",
    "vincristine"
  ],
  "seeds_initial": [
    "Corticosteroids",
    "Dantrolene",
    "Quinidine",
    "Repaglinide",
    "Simvastatin",
    "Verapamil",
    "Gemfibrozil",
    "Fluconazole",
    "Propranolol",
    "Cimetidine",
    "Furosemide",
    "Ibuprofen"
  ],
  "seed_history": [
    [
      "Corticosteroids",
      "Dantrolene",
      "Quinidine",
      "Repaglinide",
      "Simvastatin",
      "Verapamil",
      "Gemfibrozil",
      "Fluconazole",
      "Propranolol",
      "Cimetidine",
      "Furosemide",
      "Ibuprofen"
    ]
  ],
  "final_report": {
    "final_recommendations": [
      {
        "hypothesis_id": "H1",
        "candidate": {
          "id": "drug_corticosteroids",
          "name": "Corticosteroids"
        },
        "score": 0.67,
        "graph_snapshot_ref": "GE_H1_round4",
        "key_assumptions": [
          "Corticosteroids可能导致肌肉恶化",
          "安全性风险未能有效克服"
        ],
        "caveats": [
          "潜在副作用可能影响疗效",
          "与疾病表现之间的因果关系仍需验证"
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H2",
        "candidate": {
          "id": "drug_dantrolene",
          "name": "Dantrolene"
        },
        "score": 0.65,
        "graph_snapshot_ref": "GE_H2_round4",
        "key_assumptions": [
          "Dantrolene可能加重肌肉功能障碍",
          "安全性问题强调需谨慎使用"
        ],
        "caveats": [
          "还需进一步的临床数据支持其使用"
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H3",
        "candidate": {
          "id": "drug_quinidine",
          "name": "Quinidine"
        },
        "score": 0.62,
        "graph_snapshot_ref": "GE_H3_round4",
        "key_assumptions": [
          "Quinidine可能影响肌肉收缩",
          "需警惕心肌毒性"
        ],
        "caveats": [
          "缺乏针对LGMD的具体临床研究"
        ],
        "confidence": "medium"
      },
      {
        "hypothesis_id": "H4",
        "candidate": {
          "id": "drug_repaglinide",
          "name": "Repaglinide"
        },
        "score": 0.6,
        "graph_snapshot_ref": "GE_H4_round4",
        "key_assumptions": [
          "Repaglinide对肌肉代谢有潜在影响",
          "涉及风险需进一步评估"
        ],
        "caveats": [
          "临床证据不足以支持其安全性"
        ],
        "confidence": "medium"
      }
    ],
    "audit_report": {
      "decisive_graph_motifs": [
        {
          "pattern": "Drug→Disease (Corticosteroids→Limb girdle muscular dystrophy)",
          "reason": "机制归因明确，但安全性问题需要进一步澄清"
        }
      ],
      "remaining_gaps": [
        "需进一步验证药物的长期使用及其副作用"
      ]
    },
    "seed_retrospective": {
      "batches": [
        {
          "round": 1,
          "seeds": [
            "A",
            "B",
            "C",
            "D"
          ],
          "impact_summary": "种子引入了潜在的药物候选，提升了整体理解"
        },
        {
          "round": 2,
          "seeds": [
            "E",
            "F"
          ],
          "impact_summary": "补充了相关机制节点，但安全性问题依旧突出"
        }
      ],
      "lessons": [
        "关注药物的副作用及其对特定患者群体的影响",
        "确保药物使用安全性与效果的平衡"
      ]
    },
    "prompt_patches": [
      {
        "role": "Proponent",
        "patch": "尽量补充与副作用相关的机制信息，以支持假设"
      },
      {
        "role": "Skeptic",
        "patch": "强调需要具体证据支持药物对LGMD影响的有效性"
      },
      {
        "role": "Explorer",
        "patch": "关注安全性相关的文献，以获取更多候选信息"
      }
    ],
    "heuristics": []
  },
  "experience_used": true,
  "explorer_prompt": "List drugs that are contraindicated or could worsen the rare disease 'Limb girdle muscular dystrophy'. Return only names.\n\n# Prior guidance for Explorer:\n- 探索可替代药物或不同作用机制，以减少同类药物的重叠\n\n# Heuristics:\n- When 肌肉疾病相关: then 评估所有药物的长期风险及获益"
}